Clinical Trial Update: Comparison of Neointimal Coverage Between Zotarolimus Eluting Stent and Everolimus Eluting Stent [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing neointimal coverage between zotarolimus-eluting stents and everolimus-eluting stents in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor zotarolimus-eluting stent (zotarolimus)
• XIENCE everolimus-eluting stent (everolimus)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED